Alembic Pharmaceuticals has informed that the Company's joint venture, Aleor Dermaceuticals, has received US Food and Drug Administration (USFDA) Tentative Approval for Testosterone Gel, 1.62% (20.25 mg/ 1.25 gm actuation). The company has enclosed a press on 25th November 2020 regarding the announcement.
The above information is a part of company’s filings submitted to BSE.